Presentation (CTI)

OBJECTIVES: In the evolving landscape of healthcare in the US, there is increasing interest in creating a national value assessment body to standardize and enhance the evaluation of healthcare interventions. Our objective was to understand payer perspectives on a US national value assessment body, identifying potential opportunities and challenges for its development and implementation.
METHODS: A double-blinded, web-based survey of US healthcare payers was conducted through Cencora’s Managed Care Network research panel in June and July 2024.
RESULTS: A total of 51 advisors from health plans (n=26), pharmacy benefit managers (n=13), and integrated delivery networks (n=12) participated in the survey. The majority of respondents (67%) believed the US should create a national value assessment body, whereas others thought it should not (12%) or were unsure (21%). Most payers (67%) preferred a single national value assessment body, 12% preferred multiple bodies, and 21% had no preference. Payers’ perspectives on funding were split: 45% preferred a mix of governmental and private funding, 45% preferred governmental funding alone, 6% preferred private (non-governmental) funding, and 4% had no preference. If the US were to implement a national value assessment body, payers considered its ideal purpose would be to develop value assessment standards in the US (94%), conduct value assessments (61%), and evaluate the quality of value assessments conducted by third-party organizations in the US (59%). Among payers who agreed a national value assessment body should conduct or evaluate value assessments (n=42), 69% believed a national value assessment body would become their priority source of information for decision-making.
CONCLUSIONS: The majority of payers support the establishment of a single national value assessment body in the US. While the ideal purpose and funding of the body varied, most payers agreed that such a body would become a key resource for informed decision-making.